The Gross Margin of NewGLab Pharma Co Ltd (214870.KQ) is 2.22%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 2.22% |
| 2023-12-31 | 7.57% |
| 2022-12-31 | 16.38% |
| 2021-12-31 | 11.41% |
| 2020-12-31 | 16.99% |
| 2019-12-31 | 27.71% |
| 2018-12-31 | -0.02% |
| 2017-12-31 | 0.74% |
| 2016-12-31 | 6.96% |
| 2015-12-31 | 12.83% |